TCTC Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.7M | Buy |
9,733
+610
| +7% | +$623K | 0.31% | 70 |
|
|
2026
Q1 | $8.39M | Buy |
9,123
+3,534
| +63% | +$3.58M | 0.24% | 77 |
|
|
2025
Q4 | $6.01M | Buy |
5,589
+790
| +16% | +$755K | 0.18% | 85 |
|
|
2025
Q3 | $3.66M | Buy |
4,799
+2,030
| +73% | +$1.51M | 0.11% | 98 |
|
|
2025
Q2 | $2.16M | Buy |
2,769
+60
| +2% | +$46.6K | 0.07% | 104 |
|
|
2025
Q1 | $2.24M | Sell |
2,709
-18
| -0.7% | -$15K | 0.08% | 101 |
|
|
2024
Q4 | $2.11M | Buy |
2,727
+62
| +2% | +$51.3K | 0.08% | 100 |
|
|
2024
Q3 | $2.36M | Sell |
2,665
-165
| -6% | -$148K | 0.08% | 97 |
|
|
2024
Q2 | $2.56M | Sell |
2,830
-55
| -2% | -$44K | 0.09% | 95 |
|
|
2024
Q1 | $2.24M | Buy |
2,885
+6
| +0.2% | +$4.27K | 0.07% | 96 |
|
|
2023
Q4 | $1.68M | Sell |
2,879
-183
| -6% | -$107K | 0.06% | 107 |
|
|
2023
Q3 | $1.64M | Sell |
3,062
-6
| -0.2% | -$3.09K | 0.06% | 100 |
|
|
2023
Q2 | $1.44M | Hold |
3,068
| – | – | 0.06% | 111 |
|
|
2023
Q1 | $1.05M | Buy |
3,068
+272
| +10% | +$91.7K | 0.04% | 121 |
|
|
2022
Q4 | $1.02M | Hold |
2,796
| – | – | 0.04% | 114 |
|
|
2022
Q3 | $905K | Sell |
2,796
-4
| -0.1% | -$1.27K | 0.04% | 114 |
|
|
2022
Q2 | $908K | Hold |
2,800
| – | – | 0.04% | 114 |
|
|
2022
Q1 | $802K | Buy |
2,800
+197
| +8% | +$50.7K | 0.03% | 126 |
|
|
2021
Q4 | $719K | Sell |
2,603
-3
| -0.1% | -$761 | 0.03% | 126 |
|
|
2021
Q3 | $602K | Buy |
2,606
+315
| +14% | +$77.7K | 0.03% | 129 |
|
|
2021
Q2 | $526K | Sell |
2,291
-48
| -2% | -$9.64K | 0.02% | 133 |
|
|
2021
Q1 | $437K | Sell |
2,339
-50
| -2% | -$9.78K | 0.02% | 139 |
|
|
2020
Q4 | $404K | Hold |
2,389
| – | – | 0.02% | 136 |
|
|
2020
Q3 | $354K | Hold |
2,389
| – | – | 0.02% | 132 |
|
|
2020
Q2 | $392K | Hold |
2,389
| – | – | 0.02% | 126 |
|
|
2020
Q1 | $331K | Sell |
2,389
-200
| -8% | -$27.5K | 0.03% | 123 |
|
|
2019
Q4 | $341K | Buy |
2,589
+250
| +11% | +$29K | 0.02% | 134 |
|
|
2019
Q3 | $262K | Buy |
2,339
+325
| +16% | +$36.2K | 0.01% | 146 |
|
|
2019
Q2 | $223K | Hold |
2,014
| – | – | 0.01% | 159 |
|
|
2019
Q1 | $261K | Hold |
2,014
| – | – | 0.01% | 148 |
|
|
2018
Q4 | $233K | Buy |
2,014
+150
| +8% | +$16.8K | 0.01% | 149 |
|
|
2018
Q3 | $200K | Buy |
+1,864
| New | +$186K | 0.01% | 162 |
|
Other funds holding LLY
TCTC Holdings's LLY Position: Q2 2026 in Review
TCTC Holdings increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $623K and bringing the position to 9,733 shares worth $11.7M. The position accounts for 0.31% of the portfolio, ranked #70.
TCTC Holdings first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- TCTC Holdings held 9,733 shares of Eli Lilly worth $11.7M as of Q2 2026.
- TCTC Holdings bought 610 Eli Lilly shares in Q2 2026, an estimated $623K.
- Eli Lilly made up 0.31% of TCTC Holdings's portfolio in Q2 2026, its #70 holding.
- TCTC Holdings first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on TCTC Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.